PALMITIC MONOISOPROPANOLAMIDE, (R)-

CCCCCCCCCCCCCCCC(=O)NC[C@@H](C)O

InChIKey=VQNMGLLFMPXVFN-GOSISDBHSA-N

InChI=1S/C19H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19(22)20-17-18(2)21/h18,21H,3-17H2,1-2H3,(H,20,22)/t18-/m1/s1

Targets

Primary Target	Pharmacology	Condition	Potency
Cannabinoid CB1 receptor 85 Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11498512	Binding Agent 1064
Cannabinoid CB2 receptor 71 Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11498512	Binding Agent 1064

PubMed

Title	Date	PubMed
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.	2001 Aug	11498512

Patents

Name

Type

Language

PALMITIC MONOISOPROPANOLAMIDE, (R)-

Common Name

English

HEXADECANAMIDE, N-((2R)-2-HYDROXYPROPYL)-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID30170886

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

PUBCHEM

18395309

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

CAS

179951-56-5

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

FDA UNII

3438DY3589

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

SUBSTANCE RECORD


					3438DY3589